Financhill
Back

TG Therapeutics Stock Predictions

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 37.1% based on the past 29 years of stock performance.
  • TG Therapeutics has risen higher in 13 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.83%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $41.06. The Score for TGTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 37.1% based on the past 29 years of stock performance.

TG Therapeutics Stock Rating

Buy
82
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 13 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.83%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
41.85
52-Week Low:
12.93

Prediction Charts

Market Cap:
6.4B
Price in USD:
41.06
Volume:
2.4M
Beta:
0.98

Technical Analysis

SMA50:
31.99
SMA100:
31.05
SMA200:
25.85
52-Wk Change:
169.78%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 41.06 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 28.89 29.22 29.74 28.39
Feb-26 29.28 29.34 29.96 29.00
Feb-27 29.25 28.54 29.77 28.41
Feb-28 28.30 30.12 30.37 28.17
Mar-3 30.33 34.48 36.40 30.28
Mar-4 34.42 35.58 36.94 34.15
Mar-5 36.00 35.11 36.00 34.54
Mar-6 34.59 35.19 37.58 34.53
Mar-7 35.00 38.44 38.58 34.34
Mar-11 39.09 37.55 40.00 37.21
Mar-12 38.15 37.23 38.70 36.82
Mar-13 37.04 37.06 38.69 37.00
Mar-14 37.50 40.84 41.85 37.44
Mar-17 40.70 41.06 41.58 39.92

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $0.85 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.